{"id":52490,"date":"2023-01-03T19:02:29","date_gmt":"2023-01-03T18:02:29","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/"},"modified":"2023-01-03T19:02:29","modified_gmt":"2023-01-03T18:02:29","slug":"treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/","title":{"rendered":"Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5703098\/treatment-resistant-depression-clinical-trial?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=jsx984&amp;utm_campaign=1801560+-+Treatment+Resistant+Depression+Clinical+Trial+Analysis+by+Trial+Phase%2C+Trial+Status%2C+Trial+Counts%2C+End+Points%2C+Status%2C+Sponsor+Type%2C+and+Top+Countries%2C+2022+Update&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230103005690\/en\/1675582\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230103005690\/en\/1675582\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe publisher&#8217;s clinical trial report, &#8220;Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update&#8217; provides an overview of Treatment Resistant Depression Clinical trials scenario. This report provides top line data relating to the clinical trials on Treatment Resistant Depression. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.\n<\/p>\n<p>\nThe report offers coverage of disease clinical trials by region, country (G7 &amp; E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The publisher Clinical Trial Reports are generated using the publisher&#8217;s proprietary database &#8211; Pharma &#8211; Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.\n<\/p>\n<p>\nThe report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.\n<\/p>\n<p>\n<strong>Scope<\/strong>\n<\/p>\n<ul>\n<li>\nThe report provides a snapshot of the global clinical trials landscape\n<\/li>\n<li>\nReport provides top level data related to the clinical trials by Region, Country (G7 &amp; E7), Trial Status, Trial Phase, Sponsor Type and End point status\n<\/li>\n<li>\nThe report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company\n<\/li>\n<li>\nThe report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment\n<\/li>\n<li>\nThe Report provides enrollment trends for the past five years\n<\/li>\n<li>\nReport provides latest news for the past three months\n<\/li>\n<\/ul>\n<p>\nNote: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.\n<\/p>\n<p>\n<strong>Reasons to Buy<\/strong>\n<\/p>\n<ul>\n<li>\nAssists in formulating key business strategies with regards to investment\n<\/li>\n<li>\nHelps in identifying prominent locations for conducting clinical trials which saves time and cost\n<\/li>\n<li>\nProvides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities\n<\/li>\n<li>\nSupports understanding of trials count and enrollment trends by country in global therapeutics market\n<\/li>\n<li>\nAids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials\n<\/li>\n<li>\nFacilitates clinical trial assessment of the indication on a global, regional and country level\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<ul>\n<li>\nCompany Overview\n<\/li>\n<li>\nTechnology Focus\n<\/li>\n<li>\nProduct Overview\n<\/li>\n<li>\nPartnership &amp; Funding\n<\/li>\n<li>\nKey Employees\n<\/li>\n<li>\nAppendix\n<\/li>\n<\/ul>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nJohnson &amp; Johnson\n<\/li>\n<li>\nCompass Pathways Plc\n<\/li>\n<li>\nF. Hoffmann-La Roche Ltd\n<\/li>\n<li>\nAstraZeneca Plc\n<\/li>\n<li>\nBristol-Myers Squibb Co\n<\/li>\n<li>\nAxsome Therapeutics Inc\n<\/li>\n<li>\nOtsuka Holdings Co Ltd\n<\/li>\n<li>\nEli Lilly and Co\n<\/li>\n<li>\nThe Lundbeck Foundation\n<\/li>\n<li>\nAlkermes Plc\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5703098\/treatment-resistant-depression-clinical-trial?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=jsx984&amp;utm_campaign=1801560+-+Treatment+Resistant+Depression+Clinical+Trial+Analysis+by+Trial+Phase%2C+Trial+Status%2C+Trial+Counts%2C+End+Points%2C+Status%2C+Sponsor+Type%2C+and+Top+Countries%2C+2022+Update&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/wkpho0<\/a>\n<\/p>\n<p>\nSource: GlobalData\n<\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong>\n<\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x70;&#x72;&#x65;&#x73;&#x73;&#x40;&#x72;&#x65;&#x73;&#x65;&#x61;&#x72;&#x63;&#x68;&#x61;&#110;&#100;&#109;&#97;&#114;&#107;&#101;&#116;&#115;&#46;&#99;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#x65;&#x73;&#x73;&#x40;&#x72;&#x65;&#x73;&#x65;&#x61;&#x72;&#x63;&#x68;&#97;&#110;&#100;&#109;&#97;&#114;&#107;&#101;&#116;&#115;&#46;com<\/a><\/p>\n<p>For E.S.T. Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The publisher&#8217;s clinical trial report, &#8220;Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52490","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The publisher&#8217;s clinical trial report, &#8220;Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-03T18:02:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230103005690\/en\/1675582\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2023-01-03T18:02:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\\\/\"},\"wordCount\":583,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230103005690\\\/en\\\/1675582\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\\\/\",\"name\":\"Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230103005690\\\/en\\\/1675582\\\/21\\\/logo.jpg\",\"datePublished\":\"2023-01-03T18:02:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230103005690\\\/en\\\/1675582\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230103005690\\\/en\\\/1675582\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The publisher&#8217;s clinical trial report, &#8220;Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-03T18:02:29+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230103005690\/en\/1675582\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update &#8211; ResearchAndMarkets.com","datePublished":"2023-01-03T18:02:29+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/"},"wordCount":583,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230103005690\/en\/1675582\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/","name":"Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230103005690\/en\/1675582\/21\/logo.jpg","datePublished":"2023-01-03T18:02:29+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230103005690\/en\/1675582\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230103005690\/en\/1675582\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/treatment-resistant-depression-clinical-trial-analysis-by-trial-phase-trial-status-trial-counts-end-points-status-sponsor-type-and-top-countries-2022-update-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52490","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52490"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52490\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52490"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52490"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}